Altre lingue Carmell Corporation

Azioni

CTCX

US1429221039

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 17/05/2024			Variaz. 5gg	Var. 1 gen.
2,05 ^USD	-10,09%		0,00%	-46,19%

01/04	Carmell Corporation riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
26/03	Un acquirente non dichiarato ha completato l'acquisizione di Axolotl Biologix, Inc. da Carmell Corporation (NasdaqCM:CTCX).	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Carmell Announces Successful Closing of $3.0 Million Private Placement	11/04
Carmell Corporation announced that it has received $3 million in funding	11/04
Carmell Announces $3.0 Million Private Placement	04/04
Carmell Corporation announced that it expects to receive $3 million in funding	04/04
Carmell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction	27/03
An undisclosed buyer completed the acquisition of Axolotl Biologix, Inc. from Carmell Corporation.	26/03
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Fed Maintains Rate Cut Outlook	21/03
Carmell Sells Axolotl Biologix Unit -- Shares Jump Premarket	21/03
An undisclosed buyer entered into a a definitive agreement to acquire Axolotl Biologix, Inc. from Carmell Corporation ).	20/03
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	26/02
Carmell Corporation Announces Appointment of Dr. Bradley Calobrace to Scientific Advisory Board	17/01
Carmell Corp Announces Appointment of Dr. Jason D. Bloom to Scientific Advisory Board	17/01
Carmell Corporation Announces Appointment of Dr. Adam Rubinstein to Scientific Advisory Board	17/01
Carmell Corporation Announces Appointment of Dr. Gregory A. Buford to Scientific Advisory Board	17/01
Carmell Corporation Announces Appointment of Dr. Sean Kelishadi to Scientific Advisory Board	17/01
Carmell Corporation Announces Addition of Two Independent Directors	16/11
Carmell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Carmell Therapeutics Corporation(NasdaqCM:CTCX) added to S&P TMI Index	18/09/23
Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine	12/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Carmell Corporation

Azioni

CTCX

US1429221039

Altre lingue

Filtri